BioNJ collaborates with Tech Council Ventures to boost life sciences innovation

BioNJ & Tech Council Ventures

BioNJ and Tech Council Ventures are teaming up to accelerate and facilitate life sciences deals. The partnership aims to work together to support and drive innovation in the sector, especially in regard to digital health, biotech, medical devices and therapeutics companies.

By combining BioNJ’s deep-rooted network and commitment to patient access with Tech Council Ventures’ investment expertise, the collaboration will create robust opportunities through their strengths and connections for early-stage companies to thrive and expand in New Jersey.

“We are thrilled to join forces with Tech Council Ventures,” Debbie Hart, CEO and president of BioNJ said. “This collaboration will enable us to further our mission of building a dynamic life sciences ecosystem in New Jersey, ensuring that innovation flourishes and patients gain access to groundbreaking advancements.”

“Partnering with BioNJ aligns perfectly with our mission to invest in and support the most promising early-stage companies in the life sciences sector,” Jim Gunton, managing partner at Tech Council Ventures, said. “This collaboration will provide unparalleled opportunities for innovative companies to grow and succeed, benefiting from the combined strengths of our organizations.”

Tech Council Ventures is a Summit-based venture capital firm that invests in early-stage, high-growth technology companies within the Mid-Atlantic region. Tech Council Ventures’ portfolio companies benefit from the fund’s collaboration with one of the nation’s largest and most active technology councils, providing valuable introductions to customers, recruits, resellers, distributors, board directors, investors and quality service providers.